Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy D Shapiro

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 9, 2022
Quality of life in a large multinational haemophilia B cohort (The B-Natural study) - Unmet needs remainErik Berntorp, Petra LeBeau, Margaret V Ragni, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 5, 2020
Natural history study of factor IX deficiency with focus on treatment and complications (B-Natural)Amy D Shapiro, Margaret V Ragni, Munira Borhany, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 12, 2021
The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitorsMiguel Escobar, Giancarlo Castaman, Santiago Bonanad Boix, et al.
Blood|February 11, 2016
Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United StatesVeronica H Flood, Pamela A Christopherson, Joan Cox Gill, et al.
The New England Journal of Medicine|August 10, 2007
Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophiliaMarilyn J Manco-Johnson, Thomas C Abshire, Amy D Shapiro, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 27, 2022
Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitorsSteven W Pipe, Cédric Hermans, Meera Chitlur, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 9, 2022
Quality of life in a large multinational haemophilia B cohort (The B-Natural study) - Unmet needs remainErik Berntorp, Petra LeBeau, Margaret V Ragni, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 5, 2020
Natural history study of factor IX deficiency with focus on treatment and complications (B-Natural)Amy D Shapiro, Margaret V Ragni, Munira Borhany, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 12, 2021
The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitorsMiguel Escobar, Giancarlo Castaman, Santiago Bonanad Boix, et al.
Blood|February 11, 2016
Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United StatesVeronica H Flood, Pamela A Christopherson, Joan Cox Gill, et al.
The New England Journal of Medicine|August 10, 2007
Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophiliaMarilyn J Manco-Johnson, Thomas C Abshire, Amy D Shapiro, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 27, 2022
Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitorsSteven W Pipe, Cédric Hermans, Meera Chitlur, et al.
Pageof 8